Major Depressive Disorder Clinical Trial
Official title:
Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa
NCT number | NCT02615119 |
Other study ID # | 2017-002 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 1, 2015 |
Est. completion date | June 2023 |
Verified date | November 2023 |
Source | Laureate Institute for Brain Research, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study aims to identify the brain regions responsible for encoding cardiorespiratory 'interoceptive' sensations and determine whether they are dysfunctional in individuals affected by eating disorders, anxiety, depression, or brain injury. By evaluating the same interoceptive sensations across different human illnesses, the investigators hope to provide convergent evidence resulting in identification of core underlying neural processes, and to discern relative contributions in each condition.
Status | Completed |
Enrollment | 97 |
Est. completion date | June 2023 |
Est. primary completion date | June 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: - Diagnostic and Statistical Manual 5 (DSM 5) criteria for anorexia nervosa and age 18 to 40, or generalized anxiety disorder, or panic disorder, or major depressive disorder, or brain injury caused either by herpes simplex encephalitis or Urbach-Wiethe disease. Exclusion Criteria: - DSM 5 diagnosis with any of the following: Schizophrenia spectrum and other psychotic disorders, bipolar and related disorders, antisocial personality disorder, active suicidal ideation with intent or plan - Current cardiac arrhythmia - Current respiratory disease - Seizure disorder - MRI contraindications including: cardiac pacemaker, metal fragments in eyes/skin/body (shrapnel), aortic/aneurysm clips, prosthesis, by-pass surgery/coronary artery clips, hearing aid, heart valve replacement, shunt (ventricular or spinal), electrodes, metal plates/pins/screws/ wires, or neuro/bio-stimulators (TENS unit), persons who have ever been a professional metal worker/welder, history of eye surgery/eyes washed out because of metal, vision problems uncorrectable with lenses, inability to lie still on one's back for 60-120 minutes; prior neurosurgery; tattoos or cosmetic makeup with metal dyes, unwillingness to remove body piercings, and pregnancy. |
Country | Name | City | State |
---|---|---|---|
United States | Laureate Institute for Brain Research | Tulsa | Oklahoma |
Lead Sponsor | Collaborator |
---|---|
Laureate Institute for Brain Research, Inc. | National Institute of Mental Health (NIMH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Resting cardiac interoceptive sensitivity (heartbeat tapping task tap latencies (in milliseconds)) | subject taps with their finger their own perceived heart beat | Baseline | |
Other | Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic task of the valsalva maneuver | blood pressure assessed | Baseline | |
Other | Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic handgrip task. | blood pressure assessed | Baseline | |
Other | Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic task of mental arithmetic. | blood pressure assessed | Baseline | |
Other | Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic cold pressor task. | blood pressure assessed | Baseline | |
Other | Systolic and diastolic blood pressure (millimeters of mercury; mmHg) during the autonomic task of breath holding). | blood pressure assessed | Baseline | |
Other | Structural magnetic resonance imaging (cortical thickness in millimeters cubed). | Structural MRI measure: cortical thickness. | Baseline | |
Other | Functional magnetic resonance imaging (Blood Oxygenation Level Dependent i.e. BOLD signal) | Functional MRI measure: task based activation change | Baseline | |
Other | EEG (coherence in alpha, beta, theta, delta, gamma frequencies, in Hertz (Hz)) | EEG: global and local coherence. | Baseline | |
Other | Change in heart rate | Average heart rate change versus pre-infusion baseline | Baseline | |
Other | Change in breathing pattern | Average respiratory volume variability change versus pre-infusion baseline | Baseline | |
Primary | Change in cardiorespiratory sensation intensity | Visual analogue rating of intensity of heartbeat and breathing sensations (scale: 0 to 10) through study completion (e.g., the day of testing). | Baseline | |
Secondary | Change in anxiety level | Visual analog rating of level of anxiety (scale: 0 to 10) through study completion, an average of 2 weeks. | Baseline | |
Secondary | Generalized anxiety disorder severity (Generalized Anxiety Disorder 7 scale) | 7 questions on anxiety symptoms | Baseline | |
Secondary | Panic disorder severity (Panic Disorder Severity scale) | panic symptoms questionnaire | Baseline | |
Secondary | Major depressive disorder severity (Patient Health Questionnaire-9 scale) | 9 questions on depression symptoms | Baseline | |
Secondary | Eating disorder severity (Eating Disorder Examination scale) | questionnaire about eating disorder symptoms | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05537558 -
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
|
||
Terminated |
NCT02192099 -
Open Label Extension for GLYX13-C-202, NCT01684163
|
Phase 2 | |
Completed |
NCT03142919 -
Lipopolysaccharide (LPS) Challenge in Depression
|
Phase 2 | |
Recruiting |
NCT05547035 -
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
|
N/A | |
Terminated |
NCT02940769 -
Neurobiological Effects of Light on MDD
|
N/A | |
Recruiting |
NCT05892744 -
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
|
Phase 4 | |
Recruiting |
NCT05537584 -
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
|
Phase 4 | |
Active, not recruiting |
NCT05061706 -
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
|
Phase 3 | |
Completed |
NCT04479852 -
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
|
Phase 2 | |
Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
Recruiting |
NCT05527951 -
Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study
|
N/A | |
Completed |
NCT03511599 -
Cycloserine rTMS Plasticity Augmentation in Depression
|
Phase 1 | |
Recruiting |
NCT04392947 -
Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation
|
N/A | |
Recruiting |
NCT05895747 -
5-HTP and Creatine for Depression R33 Phase
|
Phase 2 | |
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Recruiting |
NCT05813093 -
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
|
N/A | |
Recruiting |
NCT05135897 -
The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
|
||
Enrolling by invitation |
NCT04509102 -
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
|
Early Phase 1 | |
Recruiting |
NCT06026917 -
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
|
Phase 4 | |
Recruiting |
NCT06145594 -
EMA-Guided Maintenance TMS for Depression
|
N/A |